CLINICAL_TRIALS
trial_result
· 2019-08-28
Clinical Trial Update: Efficacy and Safety Study of Deferasirox in Patients With Non-transfusion Dependent Thalassemia [Phase 4]
Summary
Phase 4 trial update on deferasirox for patients with non-transfusion dependent thalassemia assessing efficacy and safety; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Non-transfusion Dependent Thalassemia | Phase 4 | Status: COMPLETED | Results posted: 2019-08-28